Immunization, Hib3 in South Asia (IDA & IBRD)
South Asia (IDA & IBRD): Immunization, Hib3 was 94.5% in 2024. ◆ Volatile
Immunization, Hib3 in South Asia (IDA & IBRD), 1990–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
The most recent figure for immunization, hib3 in South Asia (IDA & IBRD) is 94.5%, measured in 2024. That is the highest value across all 35 years on record.
The figure is up 2.8% on the previous year and up 208.6% over ten years.
Over the whole period, immunization, hib3 in South Asia (IDA & IBRD) peaked at 94.5% in 2024 and was at its lowest, 0.0%, in 1990.
That places South Asia (IDA & IBRD) 1st out of 43 groups with data for 2024, putting it in the top 10%.
The series is highly variable year to year, so single readings are best treated with caution.
Immunization, Hib3 in South Asia (IDA & IBRD), year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1990 | 0.0% | — |
| 1991 | 0.0% | — |
| 1992 | 0.0% | — |
| 1993 | 0.0% | — |
| 1994 | 0.0% | — |
| 1995 | 0.0% | — |
| 1996 | 0.0% | — |
| 1997 | 0.0% | — |
| 1998 | 0.0% | — |
| 1999 | 0.0% | — |
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 0.0% | — |
| 2009 | 10.9% | — |
| 2010 | 11.5% | +5.8% |
| 2011 | 12.4% | +7.4% |
| 2012 | 13.0% | +4.7% |
| 2013 | 30.4% | +134.4% |
| 2014 | 30.6% | +0.7% |
| 2015 | 52.4% | +71.1% |
| 2016 | 82.4% | +57.2% |
| 2017 | 90.1% | +9.4% |
| 2018 | 91.0% | +1.0% |
| 2019 | 91.9% | +1.0% |
| 2020 | 86.6% | -5.8% |
| 2021 | 86.7% | +0.1% |
| 2022 | 93.5% | +7.8% |
| 2023 | 91.9% | -1.7% |
| 2024 | 94.5% | +2.8% |
Biggest year-on-year movements
Years where Immunization, Hib3 in South Asia (IDA & IBRD) changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2013 | +134.4% | 13.0% | 30.4% |
| 2015 | +71.1% | 30.6% | 52.4% |
| 2016 | +57.2% | 52.4% | 82.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 0.0% | 0.0% | 0.0% | 10 |
| 2000s | 1.1% | 0.0% | 10.9% | 10 |
| 2010s | 50.6% | 11.5% | 91.9% | 10 |
| 2020s | 90.6% | 86.6% | 94.5% | 5 |
Countries ranked near South Asia (IDA & IBRD)
- 1 Antigua and Barbuda 99.0% compare
- 1 Brunei Darussalam 99.0% compare
- 1 Costa Rica 99.0% compare
- 1 Cuba 99.0% compare
- 1 Greece 99.0% compare
- 1 Hungary 99.0% compare
- 1 Jamaica 99.0% compare
- 1 Korea, Democratic People's Republic of 99.0% compare
- 1 Kuwait 99.0% compare
- 1 Luxembourg 99.0% compare
- 1 Maldives 99.0% compare
- 1 Monaco 99.0% compare
- 1 Oman 99.0% compare
- 1 Palau 99.0% compare
- 1 Portugal 99.0% compare
- 1 Saint Lucia 99.0% compare
- 1 Saint Vincent and the Grenadines 99.0% compare
- 1 Tonga 99.0% compare
- 1 Türkiye 99.0% compare
More health data for South Asia (IDA & IBRD)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, per capita 0.0406 units per person (2025)
- Population ages 50-54, female, annual growth rate 2.35 % change on previous year (2025)
- Population ages 45-49, male, per capita 0.0305 units per person (2025)
- Population ages 45-49, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, male, annual growth rate -1.31 % change on previous year (2025)
- Population ages 45-49, male, annual growth rate 2.55 % change on previous year (2025)
- Population ages 45-49, female, per capita 0.029 units per person (2025)
- Population ages 40-44, male, annual growth rate 2.39 % change on previous year (2025)
- Population ages 10-14, male, per capita 0.0444 units per person (2025)
Frequently asked questions
- What is immunization, hib3 in South Asia (IDA & IBRD)?
- Immunization, hib3 in South Asia (IDA & IBRD) was 94.5% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in South Asia (IDA & IBRD)?
- The highest recorded value was 94.5% in 2024.
- What is the lowest immunization, hib3 recorded in South Asia (IDA & IBRD)?
- The lowest recorded value was 0.0% in 1990.
- How does South Asia (IDA & IBRD) rank for immunization, hib3?
- South Asia (IDA & IBRD) ranks 1st out of 43 groups with data for 2024.
- Is immunization, hib3 rising or falling in South Asia (IDA & IBRD)?
- Over the last ten years it is up 208.6%. The long-run trend across the full record is volatile.
- Where does this South Asia (IDA & IBRD) data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.